Thiopurine Use for IBD May Increase Incidence of Myeloid Disorders

Thiopurine Use for IBD May Increase Incidence of Myeloid Disorders
A common treatment for inflammatory bowel disease (IBD) may increase the risk for certain cancers, according to a new study from University Hospital of Nancy-Brabois in France. Researchers at University Hospital discovered that thiopurines, immunosuppressive drugs used to mitigate symptoms of and reduce inflammation in IBD, are associated with a nearly seven-fold increased risk for

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *